ZA736016B - Cholestyramine coacervate - Google Patents

Cholestyramine coacervate

Info

Publication number
ZA736016B
ZA736016B ZA00736016A ZA736016A ZA736016B ZA 736016 B ZA736016 B ZA 736016B ZA 00736016 A ZA00736016 A ZA 00736016A ZA 736016 A ZA736016 A ZA 736016A ZA 736016 B ZA736016 B ZA 736016B
Authority
ZA
South Africa
Prior art keywords
coacervate
cholestyramine
cholestyramine coacervate
Prior art date
Application number
ZA00736016A
Other languages
English (en)
Inventor
G Polli
C Shoop
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of ZA736016B publication Critical patent/ZA736016B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/785Polymers containing nitrogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
ZA00736016A 1972-09-01 1973-08-31 Cholestyramine coacervate ZA736016B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US28571972A 1972-09-01 1972-09-01

Publications (1)

Publication Number Publication Date
ZA736016B true ZA736016B (en) 1975-04-30

Family

ID=23095432

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00736016A ZA736016B (en) 1972-09-01 1973-08-31 Cholestyramine coacervate

Country Status (7)

Country Link
CA (1) CA1014472A (enrdf_load_stackoverflow)
DE (1) DE2344090A1 (enrdf_load_stackoverflow)
FR (1) FR2197592B1 (enrdf_load_stackoverflow)
GB (1) GB1446352A (enrdf_load_stackoverflow)
IL (1) IL43022A (enrdf_load_stackoverflow)
NL (1) NL7311319A (enrdf_load_stackoverflow)
ZA (1) ZA736016B (enrdf_load_stackoverflow)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4914084A (en) * 1984-05-09 1990-04-03 Synthetic Blood Corporation Composition and method for introducing heme, hemoproteins, and/or heme-hemoprotein complexes into the body
US4828857A (en) * 1984-10-05 1989-05-09 Warner-Lambert Company Novel sweetener delivery systems
US4804548A (en) * 1984-10-05 1989-02-14 Warner-Lambert Company Novel sweetener delivery systems
US4797288A (en) * 1984-10-05 1989-01-10 Warner-Lambert Company Novel drug delivery system
US4818539A (en) * 1985-02-05 1989-04-04 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4790991A (en) * 1985-02-05 1988-12-13 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4747881A (en) * 1985-02-05 1988-05-31 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4851392A (en) * 1985-02-05 1989-07-25 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4843098A (en) * 1985-02-05 1989-06-27 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
IT1190349B (it) * 1986-06-16 1988-02-16 Prodotti Formenti Srl Composizioni farmaceutiche ad attivita' sequestrante degli acidi biliari contenenti colestiramina quale principio attivo,e procedimento per prepararle
GB8628359D0 (en) * 1986-11-27 1986-12-31 Zyma Sa Galenical formulation
CA1313135C (en) * 1987-02-09 1993-01-26 The Dow Chemical Company Cholestyramine composition and process for its preparation
US5167965A (en) * 1987-02-09 1992-12-01 The Dow Chemical Company Palatable cholestyramine granules, tablets and methods for preparation thereof
ATE82680T1 (de) * 1988-05-04 1992-12-15 Smith Kline French Lab Kautablette.
US4931280A (en) * 1988-06-13 1990-06-05 Basf K & F Corporation Edible, baked compositions containing cholestyramine
US5275823A (en) * 1989-04-27 1994-01-04 Smith Kline & French Laboratories Ltd. Pharmaceutical compositions
US5102664A (en) * 1989-07-19 1992-04-07 Day Charles E Good-tasting gritty drug formulations
CA2098199C (en) * 1990-12-20 1997-06-03 Nabil George Kardouche Psyllium and cholestyramine compositions with improved palatability
AU3812893A (en) * 1992-03-20 1993-10-21 Procter & Gamble Company, The Anion exchange resin compositions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3499960A (en) * 1965-01-25 1970-03-10 Merck & Co Inc Palatable coated particles of an anion exchange resin

Also Published As

Publication number Publication date
NL7311319A (enrdf_load_stackoverflow) 1974-03-05
AU5946073A (en) 1975-02-27
CA1014472A (en) 1977-07-26
IL43022A (en) 1976-07-30
IL43022A0 (en) 1974-01-14
FR2197592A1 (enrdf_load_stackoverflow) 1974-03-29
DE2344090A1 (de) 1974-03-21
FR2197592B1 (enrdf_load_stackoverflow) 1976-08-13
GB1446352A (en) 1976-08-18

Similar Documents

Publication Publication Date Title
ZA733760B (en) Oxazolo- and thiazolopyridines
JPS5182539A (en) Deijitaru deetashorisochi
ZA734129B (en) Trifluoromethylmercaptoacetamidocephalosporins
ZA736016B (en) Cholestyramine coacervate
CS283873A2 (en) Zpusob rafinace tavenin zeleznych kovu
ZA735215B (en) 4-nitropyrazoles
AU6329873A (en) Flameprofing
IL41048A0 (en) Aminobenzimidazoles
AU5993373A (en) N-sulphenylated carbamidoximes
AU6362373A (en) N-propargylacetanilide herbicedes
GB1401579A (en) Indolo-quinolizines
PL177262A1 (en) Sposob wytwarzania nowych benzenosulfonylomocznikow
AU5711073A (en) Benzenesulfonyl-ureas benzenesulfonyl-ureas
AU6332973A (en) Bulbholders
IL42202A0 (en) Cycloalkyllactamimides
AU5191873A (en) Benzylpyrimidines
AU5233473A (en) Nitro-imidazolyl-pyrimidines
AU5983773A (en) Alkylsulphonyl-2-trifluoromethyl-benzimidazoles
JPS4945733A (en) Kairyosareta zoanteikaofukumu zokirokuho
GB1400667A (en) 4-spirocyclopropyl-androstenes
IE40492L (en) Pighouse construction
AU5900173A (en) Thiazolopyrimidines
IL42422A0 (en) Oxazolo-and thiazolo-pyridines
AU6379973A (en) Goniolens
GB1400604A (en) 2-acyl-5-nitrothiazoles